Original language | English (US) |
---|---|
Pages (from-to) | 157 |
Number of pages | 1 |
Journal | Clinical Lymphoma, Myeloma and Leukemia |
Volume | 10 |
Issue number | 2 |
DOIs |
|
State | Published - Apr 2010 |
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Erratum : Ofatumumab, a novel CD20 monoclonal antibody, is active in patients with fludarabine- and alemtuzumab-refractory or bulky fludarabine-refractory chronic lymphocytic leukemia irrespective of prior rituximab (Clinical lymphoma & Myeloma (2009) 9: 6 (E36) DOI: 10.3816/CLM.2009.n.098). / Wierda, William; Kipps, Thomas; Mayer, Jiří; Stilgenbauer, Stephan; Williams, Cathy D.; Hellmann, Andrzej; Robak, Tadeusz; Furman, Richard R.; Hillmen, Peter; Trneny, Marek; Dyer, Martin J.S.; Padmanabhan, Swami; Piotrowska, Magdalena; Kozak, Tomas; Chan, Geoffrey; Davis, Randy; Losic, Nedjad; Wilms, Joris; Russell, Charlotte; Österborg, Anders.
In: Clinical Lymphoma, Myeloma and Leukemia, Vol. 10, No. 2, 04.2010, p. 157.Research output: Contribution to journal › Comment/debate › peer-review
}
TY - JOUR
T1 - Erratum
T2 - Ofatumumab, a novel CD20 monoclonal antibody, is active in patients with fludarabine- and alemtuzumab-refractory or bulky fludarabine-refractory chronic lymphocytic leukemia irrespective of prior rituximab (Clinical lymphoma & Myeloma (2009) 9: 6 (E36) DOI: 10.3816/CLM.2009.n.098)
AU - Wierda, William
AU - Kipps, Thomas
AU - Mayer, Jiří
AU - Stilgenbauer, Stephan
AU - Williams, Cathy D.
AU - Hellmann, Andrzej
AU - Robak, Tadeusz
AU - Furman, Richard R.
AU - Hillmen, Peter
AU - Trneny, Marek
AU - Dyer, Martin J.S.
AU - Padmanabhan, Swami
AU - Piotrowska, Magdalena
AU - Kozak, Tomas
AU - Chan, Geoffrey
AU - Davis, Randy
AU - Losic, Nedjad
AU - Wilms, Joris
AU - Russell, Charlotte
AU - Österborg, Anders
PY - 2010/4
Y1 - 2010/4
UR - http://www.scopus.com/inward/record.url?scp=84860605156&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84860605156&partnerID=8YFLogxK
U2 - 10.3816/CLML.2010.n.024
DO - 10.3816/CLML.2010.n.024
M3 - Comment/debate
AN - SCOPUS:84860605156
VL - 10
SP - 157
JO - Clinical Lymphoma, Myeloma and Leukemia
JF - Clinical Lymphoma, Myeloma and Leukemia
SN - 2152-2650
IS - 2
ER -